Chronic pain is less a single condition than a category covering many different underlying causes, which makes a precise diagnosis the essential first step before any treatment conversation, including one about stem cell therapy. This page explains how chronic pain is typically assessed, what standard care involves, and what current research can and cannot show, so you can have an informed discussion before requesting an assessment.
Symptoms and Diagnosis
Chronic pain is generally defined as pain persisting beyond 3 months, often outlasting the original injury or cause. It can be localised to a specific joint or area, or more widespread.
| Pain Category | Common Examples |
| Musculoskeletal | Joint pain, back pain, tendon-related pain |
| Neuropathic | Nerve-related pain, often described as burning, tingling, or shooting |
| Inflammatory | Pain linked to autoimmune or inflammatory conditions |
| Widespread/centralised | Conditions such as fibromyalgia, involving broader pain processing changes |
Diagnosis typically involves:
- Detailed history and physical examination, identifying the pain’s pattern, triggers, and likely source
- Imaging, such as X-ray or MRI, where a structural cause is suspected
- Blood tests, when an inflammatory or autoimmune cause is being considered
- Pain specialist or relevant referral, particularly for pain that hasn’t responded to initial management, or where the underlying cause remains unclear
Because “chronic pain” covers such a broad range of underlying conditions, establishing an accurate diagnosis is essential before any meaningful discussion of treatment options, including whether stem cell therapy is relevant at all.
Standard Care for Chronic Pain
Pain management in Malaysia typically follows a structured, multi-disciplinary approach rather than relying on any single treatment.
| Approach | Purpose |
| Physiotherapy and movement-based therapy | Addressing underlying mechanical or musculoskeletal contributors |
| Medication | Pain relief tailored to the specific pain type (e.g. anti-inflammatory, neuropathic pain agents) |
| Targeted injections | Corticosteroid, nerve block, or other procedures depending on diagnosis |
| Psychological support | Pain management strategies, particularly for chronic, centralised pain conditions |
| Treating the underlying cause | Addressing the specific condition driving the pain, whether structural, inflammatory, or neuropathic |
| Multi-disciplinary pain clinics | For complex or treatment-resistant chronic pain |
This structured approach remains the evidence-based foundation of chronic pain management, and any discussion of stem cell therapy should be understood as relevant only to specific, diagnosed underlying causes, not as a general treatment for chronic pain broadly.
What Current Research Can and Cannot Show
Stem cell research relevant to pain is not a single body of evidence, it varies enormously depending on the underlying condition actually being studied.
What current research suggests, depending on the specific condition:
- For joint-related pain, such as knee osteoarthritis, there is a more developed, though still mixed, body of MSC research
- For certain inflammatory conditions, early research has explored MSCs’ immune-modulating properties
- For neuropathic or centralised pain conditions, relevant stem cell research remains considerably more limited and early-stage
What current evidence does not establish:
- There is no universal stem cell treatment proven effective across chronic pain broadly, evidence is specific to certain diagnosed conditions and varies significantly in strength
- No regulatory authority has approved stem cell therapy as a general chronic pain treatment
- Results are highly dependent on accurate diagnosis of the underlying cause, a mismatch here is one of the most common reasons treatment doesn’t help
- Long-term durability of benefit, where present, is inconsistently documented across the field
At 23C Regen, we do not offer stem cell therapy as a blanket treatment for chronic pain. Any assessment depends entirely on first establishing an accurate diagnosis, and then reviewing what evidence, if any, is relevant to that specific condition.
Risks and Exclusions
General risks associated with MSC administration can include:
- Procedure-related discomfort, swelling, or infection risk, depending on administration route
- Rare allergic or immune responses
- The risk of treating a symptom (pain) without having addressed its actual underlying cause
Patients who may be excluded from assessment or treatment can include those with:
- No clear diagnosed underlying cause for their pain
- Active infection at or near the relevant treatment site
- Active malignancy, pending oncology clearance
- Pain primarily driven by a condition with no relevant supporting evidence for cell-based therapy
- Uncontrolled bleeding disorders
Assessment Records You’ll Need
- Relevant imaging or diagnostic test results, specific to your diagnosed condition
- Specialist consultation notes, if you’ve already seen a relevant specialist (orthopaedic, rheumatology, neurology, pain clinic)
- A record of treatments already tried
- Current medications
- Any formal pain diagnosis documentation, where available
Follow-Up
Chronic pain management is typically an ongoing process regardless of treatment path. Our approach includes:
- A clear explanation of your diagnosis and realistic options following assessment
- Honest guidance on whether stem cell therapy is relevant to your specific, diagnosed condition
- Coordination notes you can share with your treating specialist or pain clinic
- Scheduled review points if you proceed with treatment, tracking actual functional and pain outcomes
Questions to Discuss During Your Assessment
- What is the specific, underlying diagnosis behind my chronic pain?
- Is there relevant evidence for stem cell therapy for this specific diagnosis, or is evidence limited?
- How does this fit alongside my current pain management plan?
- What are the risks specific to my situation?
- How will my response to treatment actually be measured?
Why Diagnosis Comes Before Any Treatment Discussion
It’s worth being direct about why this page leads so heavily with diagnosis rather than treatment. “Chronic pain” describes a symptom, not a specific medical condition, and two patients both reporting long-standing joint pain could have entirely different underlying causes, one structural, one inflammatory, one neuropathic, each with a completely different evidence picture for any regenerative approach. Treating the pain without first identifying its actual source risks both wasted time and a treatment plan that was never going to be relevant to what’s actually happening in your body.
Related Condition-Specific Pages
If your chronic pain has already been diagnosed as stemming from a specific condition, you may find more directly relevant information on a dedicated condition page rather than this general overview:
- Knee Osteoarthritis – for diagnosed joint-related knee pain
- Chronic Kidney Disease – where pain is linked to kidney-related complications
If your diagnosis doesn’t fit clearly into an existing condition page, a general chronic pain assessment is the appropriate starting point.
Frequently Asked Questions
Is stem cell therapy a general treatment for all chronic pain?
No. Relevant evidence varies significantly by the specific underlying diagnosis. There is no universal stem cell treatment proven effective across chronic pain broadly.
Do I need a diagnosis before being assessed for stem cell therapy?
Yes. An accurate underlying diagnosis is essential, since relevant evidence and suitability depend entirely on what’s actually causing your pain.
Will this replace my current pain medication?
We cannot guarantee that. Any assessment is intended to complement, not replace, your existing pain management plan unless your doctor advises otherwise.
Is this suitable for fibromyalgia or widespread, centralised pain?
Relevant research for centralised pain conditions remains limited. This would be discussed honestly during assessment based on current evidence.
What type of stem cells are used for pain-related conditions?
We use laboratory-cultured Wharton’s Jelly-derived mesenchymal stem cells. The specific protocol depends entirely on your diagnosed underlying condition.
What if my pain diagnosis isn’t clear yet?
We may recommend further diagnostic evaluation or specialist referral first, since treatment decisions depend on an accurate underlying diagnosis.
Request a Chronic Pain Assessment
If you have a diagnosed condition behind your chronic pain and want an honest conversation about what current research can and cannot offer, request an assessment.